30277H1
Transfusion Products of Conception, Circulatory to Nonautologous with Whole Blood, Via Natural or Artificial Opening Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 3 Administration |
| Body System | 0 Circulatory |
| Operation | 2 Transfusion |
| Body Part | 7 Products of Conception, Circulatory |
| Approach | 7 Via Natural or Artificial Opening |
| Device | H Whole Blood |
| Qualifier | 1 Nonautologous |
Operation Definition
Putting in blood or blood products
Procedure Overview
Transfusion is the administration of blood or a blood-derived product directly into a patient's circulation, most commonly packed red blood cells, platelets, fresh frozen plasma, or cryoprecipitate. It is used to treat significant blood loss, severe anemia, clotting disorders, or shortages of specific blood components caused by disease or treatment such as chemotherapy.
For a patient, a transfusion means receiving donated or, less commonly, their own previously collected blood through an intravenous line. The goal is to quickly restore oxygen-carrying capacity, clotting ability, or blood volume when the body cannot do so on its own. Transfusions are generally short procedures performed at the bedside, though the underlying condition prompting them can range from routine surgical blood loss to a life-threatening hemorrhage.
Anatomy & Axis Detail
Products of Conception, Circulatory
Products of conception, circulatory, refers to transfusion delivered into the fetal or placental circulation rather than the mother's own vasculature, most often performed as an intrauterine transfusion for severe fetal anemia such as that caused by Rh alloimmunization or parvovirus infection. The procedure requires ultrasound-guided needle access into the umbilical vein or, less commonly, the fetal peritoneal cavity, making it technically distinct from any transfusion into maternal vessels. Because the fetus is the recipient, precise blood typing, irradiation, and volume calculation based on gestational age and fetal weight are critical to avoid volume overload or cardiac compromise. Documentation must clearly identify the fetal circulatory target rather than the mother's vein, since misclassification would obscure the fact that the products of conception, not the pregnant patient, received the transfused substance.
Approach: Via Natural or Artificial Opening
Via Natural or Artificial Opening in Administration covers substances introduced through an existing body orifice or stoma, such as an oral medication swallowed, a rectal suppository, or a drug instilled through a gastrostomy tube, without endoscopic guidance. It is distinguished from the Endoscopic variant by the lack of a scope, and from Percutaneous by using a natural passage rather than a puncture.
Substance: Whole Blood
Whole Blood indicates that unseparated blood, containing red cells, white cells, platelets, and plasma together, is the substance administered, generally reserved for significant acute blood loss requiring full blood component replacement. It differs from Serum Albumin and Frozen Plasma, which are individual blood-derived components rather than complete blood, and from Bone Marrow, which is administered for hematopoietic reconstitution rather than volume or oxygen-carrying replacement.
Qualifier: Nonautologous
This Administration qualifier marks a transfused substance, usually blood or a blood product, as coming from a donor other than the patient. It is the general counterpart to Autologous, and is further broken down elsewhere by donor relationship into related and unrelated allogeneic sources for certain transfusion products such as bone marrow or stem cells.
Coding & Documentation
Assigning a code from this family depends on documentation specifying the exact blood product given, whether it was autologous or from a donor, and the vessel or route used for infusion, such as a peripheral vein or central venous catheter. Nursing and physician notes recording units transfused, product type, and any reaction are the primary support for the code. A recurring error is selecting the wrong substance qualifier, for example coding platelets when frozen plasma was actually given, or overlooking that autologous blood requires a different qualifier than banked donor blood. Coders should also confirm the route matches what is documented rather than defaulting to peripheral vein.